Influenza vaccines: Unmet needs and recent developments
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Noh, J.Y. | - |
dc.contributor.author | Kim, W.J. | - |
dc.date.accessioned | 2021-09-06T09:46:06Z | - |
dc.date.available | 2021-09-06T09:46:06Z | - |
dc.date.created | 2021-06-17 | - |
dc.date.issued | 2013 | - |
dc.identifier.issn | 2093-2340 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/105893 | - |
dc.description.abstract | Influenza is a worldwide public health concern. Since the introduction of trivalent influenza vaccine in 1978, vaccination has been the primary means of prevention and control of influenza. Current influenza vaccines have moderate efficacy, good safety, and acceptable tolerability; however, they have unsatisfactory efficacy in older adults, are dependent on egg supply for production, and are time-consuming to manufacture. This review outlines the unmet medical needs of current influenza vaccines. Recent developments in influenza vaccines are also described. © 2013 by The Korean Society of Infectious Diseases. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.subject | hemagglutinin | - |
dc.subject | inactivated vaccine | - |
dc.subject | influenza vaccine | - |
dc.subject | recombinant hemagglutinin influenza vaccines | - |
dc.subject | unclassified drug | - |
dc.subject | culture technique | - |
dc.subject | drug megadose | - |
dc.subject | food and drug administration | - |
dc.subject | health care need | - |
dc.subject | human | - |
dc.subject | influenza | - |
dc.subject | pandemic influenza | - |
dc.subject | review | - |
dc.subject | vaccination | - |
dc.title | Influenza vaccines: Unmet needs and recent developments | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Noh, J.Y. | - |
dc.contributor.affiliatedAuthor | Kim, W.J. | - |
dc.identifier.doi | 10.3947/ic.2013.45.4.375 | - |
dc.identifier.scopusid | 2-s2.0-84893172926 | - |
dc.identifier.bibliographicCitation | Infection and Chemotherapy, v.45, no.4, pp.375 - 386 | - |
dc.relation.isPartOf | Infection and Chemotherapy | - |
dc.citation.title | Infection and Chemotherapy | - |
dc.citation.volume | 45 | - |
dc.citation.number | 4 | - |
dc.citation.startPage | 375 | - |
dc.citation.endPage | 386 | - |
dc.type.rims | ART | - |
dc.type.docType | Review | - |
dc.identifier.kciid | ART001841192 | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
dc.subject.keywordPlus | hemagglutinin | - |
dc.subject.keywordPlus | inactivated vaccine | - |
dc.subject.keywordPlus | influenza vaccine | - |
dc.subject.keywordPlus | recombinant hemagglutinin influenza vaccines | - |
dc.subject.keywordPlus | unclassified drug | - |
dc.subject.keywordPlus | culture technique | - |
dc.subject.keywordPlus | drug megadose | - |
dc.subject.keywordPlus | food and drug administration | - |
dc.subject.keywordPlus | health care need | - |
dc.subject.keywordPlus | human | - |
dc.subject.keywordPlus | influenza | - |
dc.subject.keywordPlus | pandemic influenza | - |
dc.subject.keywordPlus | review | - |
dc.subject.keywordPlus | vaccination | - |
dc.subject.keywordAuthor | Human | - |
dc.subject.keywordAuthor | Influenza | - |
dc.subject.keywordAuthor | Influenza vaccines | - |
dc.subject.keywordAuthor | Pandemics | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
145 Anam-ro, Seongbuk-gu, Seoul, 02841, Korea+82-2-3290-2963
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.